-
Brand Name: TIBOFEM
-
Generic Name: Tibolone
-
Therapeutic Class: Synthetic Steroid with estrogenic, progestogenic, and androgenic activity
-
Presentation: 2.5 mg film-coated tablets
2. Composition
-
Active Ingredient: Tibolone 2.5 mg
-
Excipients:
-
Lactose monohydrate
-
Maize starch
-
Magnesium stearate
-
Hypromellose
-
3. Mechanism of Action
Tibolone is metabolized into 3 active compounds:
-
Δ4-isomer (progestogenic/androgenic effects)
-
3α-OH & 3β-OH metabolites (estrogenic effects)
Key Effects:
✔ Relieves menopausal symptoms (hot flashes, vaginal dryness)
✔ Prevents bone loss (osteoporosis)
✔ Endometrial protection (no need for additional progestogen)
✔ Improves libido (mild androgenic activity)
4. Dosage & Administration
-
Standard Dose: 2.5 mg once daily (oral)
-
Initiation: Start at least 12 months after last menstrual period
-
Missed Dose: Take as soon as remembered (skip if next dose is due)
-
Administration: Can be taken with/without food
5. Indications
✅ Postmenopausal symptom relief (vasomotor, urogenital)
✅ Prevention of osteoporosis in high-risk women
✅ Libido enhancement in postmenopausal women
6. Storage & Stability
-
Temperature: Below 30°C
-
Humidity: Keep in original packaging
-
Shelf Life: 3 years
-
Protection: Avoid moisture
7. Key Recommendations
✔ Not for perimenopausal women (wait ≥1 year after last period)
✔ Monitor breast health annually (mammography as needed)
✔ Assess venous thromboembolism risk before prescribing
✔ Consider non-hormonal alternatives for women with CVD risk
8. Important Safety Notes
⚠ Contraindications:
❌ Active/past hormone-dependent cancers
❌ Undiagnosed vaginal bleeding
❌ History of venous thromboembolism
❌ Severe hepatic disease
⚠ Adverse Effects:
-
Common: Headache, vaginal bleeding, weight gain
-
Serious:
-
Increased risk of stroke in women >60 years
-
Possible breast cancer risk (similar to other HRT)
-
⚠ Drug Interactions:
-
Strong CYP3A4 inducers (e.g., rifampicin) → reduced efficacy
-
Anticoagulants → may require dose adjustment
9. Comparison with Traditional HRT
Parameter | TIBOFEM | Estrogen+Progestogen HRT |
---|---|---|
Endometrial Protection | Built-in | Requires progestogen |
Bleeding Profile | Spotting common | Regular withdrawal bleeding |
Libido Effect | Positive (androgenic) | Neutral/negative |
VTE Risk | Lower than oral HRT | Higher |
10. Patient Counseling
✔ Take at the same time daily for consistent effects
✔ Report unusual vaginal bleeding immediately
✔ Attend regular breast/gynecological check-ups
✔ Combine with calcium/vitamin D for bone health
Conclusion
TIBOFEM offers unique tissue-selective benefits for postmenopausal women, combining symptom relief, bone protection, and libido support in a single tablet. However, it requires careful patient selection and monitoring due to potential risks.
Reviews
There are no reviews yet.